-
Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson’s disease
-
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
-
Onset and stabilization of opicapone treatment effects in fluctuating Parkinson’s disease patients: Exploratory by-week efficacy analysis of pooled phase III studies
-
Onset-related subtypes of Parkinson’s disease differ in the patterns of striatal functional connectivity: A resting-state functional MRI study
-
Opicapone in fluctuating Parkinson’s disease patients: OFF- and ON-time responder post-hoc analyses of pooled phase III studies
-
Opioid K receptor variant delays the onset of dyskinesias in Parkinson’s disease
-
Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report
-
Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease
-
Optimization of 6-hydroxydopamine animal model of early stage Parkinson´s disease for the assessment of neurorestorative therapies
-
Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 207
- Next Page »